Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Alkem Laboratories Management Change

Alkem Laboratories appointed Dr. Amrut Naik as CEO effective November 11, 2026. The Board designated him as Key Managerial Personnel at its November 3 meeting.

Source

NSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Alkem Laboratories Ltd: key numbers

Share price
₹5,233.50
Market cap
₹62,574 Cr
Revenue (annual)
₹14,712 Cr
Net profit (annual)
₹2,302 Cr
P/E (TTM)
29.0×Sector 47.2×
Promoter holding
49.70%+0.00% QoQ
FII holding
10.32%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Alkem Laboratories Ltd

All →

Other management change announcements

All →